Nilesh J Samani Selected Research

Lipoprotein(a)

1/2022	Cis-epistasis at the LPA locus and risk of cardiovascular diseases.
1/2017	Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
12/2016	Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels.
8/2012	Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nilesh J Samani Research Topics

Disease

49	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2003
46	Heart Failure 10/2022 - 01/2010
33	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2007
25	Myocardial Infarction 01/2022 - 03/2004
24	Coronary Disease (Coronary Heart Disease) 11/2020 - 05/2003
21	Hypertension (High Blood Pressure) 01/2022 - 09/2002
19	Atherosclerosis 01/2020 - 10/2003
16	Inflammation (Inflammations) 01/2022 - 03/2004
11	Stroke (Strokes) 10/2019 - 03/2004
11	Obesity 07/2019 - 01/2014
10	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2008
8	Atrial Fibrillation 10/2021 - 11/2005
5	Vascular Diseases (Vascular Disease) 04/2022 - 08/2012
5	Diabetes Mellitus 11/2020 - 03/2010
5	Atherosclerotic Plaque (Atheroma) 11/2020 - 01/2011
5	Thrombosis (Thrombus) 11/2020 - 11/2010
5	Abdominal Aortic Aneurysm 05/2019 - 10/2007
5	Neoplasms (Cancer) 01/2019 - 04/2013
4	Heart Diseases (Heart Disease) 12/2021 - 06/2015
4	COVID-19 08/2021 - 01/2020
4	Insulin Resistance 10/2014 - 11/2009
3	Venous Thromboembolism 01/2022 - 08/2012
3	Ischemic Stroke 01/2022 - 08/2012
3	Necrosis 01/2022 - 01/2020
3	Peripheral Arterial Disease 01/2022 - 08/2012
3	Liver Diseases (Liver Disease) 04/2021 - 05/2015
3	Cardiomyopathies (Cardiomyopathy) 01/2020 - 12/2014
3	Disease Progression 01/2020 - 07/2017
3	Genetic Risk Score 01/2018 - 06/2015
3	Glioma (Gliomas) 05/2017 - 07/2014
3	Hypoxia (Hypoxemia) 11/2015 - 08/2008
3	Gout 02/2013 - 10/2008
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 12/2016
2	Chronic Renal Insufficiency 10/2021 - 05/2010
2	Spontaneous Coronary Artery Dissection 04/2021 - 01/2021
2	Pathologic Constriction (Stenosis) 01/2021 - 02/2012
2	Rupture 11/2020 - 01/2003
2	Renal Insufficiency (Renal Failure) 11/2020 - 07/2017
2	Iron Deficiencies 08/2020 - 01/2019
2	Hypertrophy 01/2020 - 02/2012
2	Fibrosis (Cirrhosis) 01/2020 - 02/2012
2	Infarction (Infarctions) 01/2020 - 12/2018
2	Genetic Predisposition to Disease (Genetic Predisposition) 12/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

28	Biological ProductsIBA 01/2022 - 05/2003
27	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
23	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2004
22	LipidsIBA 12/2021 - 01/2008
10	LDL CholesterolIBA 12/2021 - 08/2008
9	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2021 - 01/2010
9	CholesterolIBA 01/2020 - 11/2008
8	EnzymesIBA 07/2021 - 05/2010
8	HDL CholesterolIBA 01/2018 - 08/2010
8	Triglycerides (Triacylglycerol)IBA 01/2017 - 05/2010
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2007
7	oxidized low density lipoproteinIBA 10/2020 - 09/2009
6	Pharmaceutical PreparationsIBA 10/2022 - 10/2008
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2018
5	C-Reactive ProteinIBA 01/2016 - 10/2008
4	Lipoprotein(a)IBA 01/2022 - 08/2012
4	pro-brain natriuretic peptide (1-76)IBA 10/2021 - 03/2020
4	MicroRNAs (MicroRNA)IBA 04/2021 - 04/2015
4	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2018
4	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 08/2010
4	Insulin (Novolin)FDA Link 01/2019 - 01/2012
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2007
4	CytokinesIBA 01/2019 - 01/2010
4	HDL LipoproteinsIBA 01/2018 - 01/2016
4	Glucose (Dextrose)FDA LinkGeneric 06/2016 - 01/2012
4	telomerase RNA (bTR)IBA 01/2016 - 04/2013
4	P-2 (P 2)IBA 01/2016 - 01/2009
4	Uric Acid (Urate)IBA 02/2013 - 01/2008
3	Endothelial Protein C ReceptorIBA 04/2022 - 07/2017
3	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022 - 01/2019
3	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 10/2017
3	CreatinineIBA 01/2021 - 07/2013
3	Angiotensin-Converting Enzyme 2IBA 12/2020 - 01/2020
3	RNA (Ribonucleic Acid)IBA 12/2020 - 04/2015
3	HomocysteineIBA 12/2019 - 02/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 12/2013
3	SodiumIBA 10/2017 - 10/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 10/2014
3	MorpholinosIBA 11/2015 - 11/2010
3	AdiponectinIBA 09/2014 - 12/2009
3	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 08/2008 - 03/2004
2	LigandsIBA 01/2022 - 11/2009
2	Growth Differentiation Factor 15IBA 08/2021 - 03/2020
2	amidoximeIBA 04/2021 - 01/2020
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021 - 08/2020
2	Interleukin-6 (Interleukin 6)IBA 11/2020 - 01/2019
2	Phytosterols (Plant Sterols)IBA 10/2020 - 08/2010
2	SeleniumIBA 08/2020 - 01/2020
2	AldosteroneIBA 01/2020 - 01/2020
2	FurinIBA 01/2020 - 01/2018
2	ReninIBA 01/2020 - 01/2020
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2020 - 08/2006
2	GadoliniumIBA 01/2020 - 02/2012
2	PotassiumIBA 12/2019 - 01/2018
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2019 - 01/2018

Therapy/Procedure

15	Therapeutics 08/2022 - 02/2011
3	Percutaneous Coronary Intervention 01/2022 - 12/2018